SCHEMBL7749673

SCHEMBL7749673

Cc1cccc(N2CCN(C(Cc3ccc(C#N)cc3)c3cnc[nH]3)CC2=O)c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 9/20 0.53
FNTB P49356 9/20 0.53
PGGT1B P53609 3/20 0.44
CYP19A1 P11511 5/20 0.35
ADRA2A P08913 4/20 0.35
ADRA2B P18089 4/20 0.35
ADRA2C P18825 4/20 0.35
ADRA1A P35348 3/20 0.35
ADRA1B P35368 3/20 0.35
ADRA1D P25100 2/20 0.35
KCNH2 Q12809 1/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35
NRAS P01111 1/20 0.34
HRAS P01112 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2370713 0.93 FNTA (0.45) FNTAFNTBPGGT1BCYP19A1NRAS
SCHEMBL7515948 0.87 FNTA (0.41) FNTAFNTBPGGT1BCYP19A1NRAS
SCHEMBL7453424 0.85 FNTA (0.53) FNTAFNTBPGGT1BCYP19A1ADRA2A
SCHEMBL3498159 0.83 FNTA (0.38) FNTAFNTBPGGT1BCYP19A1NRAS
SCHEMBL3500065 0.83 FNTA (0.35) FNTAFNTBPGGT1BCYP19A1ADRA1D
Hydrochloric Acid SCHEMBL7655739 0.83 FNTA (0.37) FNTAFNTBPGGT1BCYP19A1NRAS
Hydrochloric Acid SCHEMBL7662498 0.82 ADRA1D (0.35) FNTAFNTBPGGT1BCYP19A1ADRA1D
SCHEMBL1683543 0.82 FNTA (0.53) FNTAFNTBPGGT1BNRASHRAS
SCHEMBL7972250 0.82 FNTA (0.53) FNTAFNTBPGGT1BNRASHRAS
Water SCHEMBL7194386 0.82 FNTA (0.53) FNTAFNTBPGGT1BNRASHRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0906099-A4 A METHOD OF TREATING CANCER MERCK & CO INC (US) 2001-02-07 EP claimed
EP-0952842-A2 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 1999-11-03 EP claimed
EP-0906099-A1 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 1999-04-07 EP claimed
WO-1997038664-A2 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1997-10-23 WO claimed
WO-1997036587-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1997-10-09 WO claimed
EP-0952842-A2 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 1999-11-03 EP disclosed
WO-1997038664-A2 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1997-10-23 WO disclosed